Palisade Bio (PALI) Other Accumulated Expenses (2012 - 2026)

Palisade Bio (PALI) has 15 years of Other Accumulated Expenses data on file, last reported at $219000.0 in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $219000.0 in Q1 2026; TTM through Mar 2026 was $219000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $433000.0, up 448.1% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $219000.0, down from $433000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for PALI reached as high as $433000.0 in Q4 2025 and fell as low as $11000.0 in Q2 2022.
• Historically, Other Accumulated Expenses has averaged $174833.3 across 5 years, with a median of $184500.0 in 2023.
• Across the five-year window, Other Accumulated Expenses slumped 86.25% in 2022 and surged 1354.17% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $11000.0 in 2022, then jumped by 1336.36% to $158000.0 in 2023, then slumped by 50.0% to $79000.0 in 2024, then soared by 448.1% to $433000.0 in 2025, then slumped by 49.42% to $219000.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $219000.0 in Q1 2026, $433000.0 in Q4 2025, and $211000.0 in Q3 2025.